Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering.Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental…
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
